ArticleJournal of translational medicine2023

Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway.

Huhu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.